Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Nutrition Vol. 124 No. 12_Suppl December 1994, pp. 2687-2692
Copyright © 1994 by American Society for Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Costa, N. D.
Right arrow Articles by Labuc, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Costa, N. D.
Right arrow Articles by Labuc, R. H.

Case Report: Efficacy of Oral Carnitine Therapy for Dilated Cardiomyopathy in Boxer Dogs1

Nick D. Costa2 and Robert H. Labuc

School of Veterinary Studies, Murdoch University, Murdoch, WA Australia 6150

This paper investigates the role of carnitine in the etiology and treatment of dilated cardiomyopathy in boxers. Two boxers were diagnosed as having dilated cardiomyopathy on the basis of clinical presentation, chest radiographs, electrocardiography and echocardiography. In one dog, carnitine was administered at 6.0 g (or ~250 mg/kg live weight (LW) daily per os, and this dog remained asymptomatic for 4 mo until it presented for anorexia, coughing and weakness. Necropsy and histologic findings were consistent with boxer cardiomyopathy in both dogs. Cardiac carnitine concentration was 567 nmol/g wet weight in the unsupplemented dog, which is below the normal mean ± SD concentration of 1493 ± 141 nmol/g wet weight. Low cardiac carnitine concentrations appear to be a consistent finding for dilated cardiomyopathy in boxers. However, in the dog that received carnitine therapy, cardiac carnitine was 2802 nmol/g wet weight, and all tissues assayed in the supplemented dog had higher carnitine concentrations than normal dogs. Elevation of tissue carnitine failed to ameliorate dilated cardiomyopathy in this dog. Oral carnitine supplementation in these therapeutic doses appears not to resolve dilated cardiomyopathy in all boxers.


KEY WORDS: • dogs • carnitine • cardiomyopathy

1 Presented as part of the Waltham Symposium on the Nutrition of Companion Animals in association with the 15th International Congress of Nutrition, at Adelaide, SA, Australia, on September 23–25, 1993. Guest editors for this symposium were Kay Earle, John Mercer and D'Ann Finley.

2 To whom correspondence should be addressed: School of Veterinary Studies, Murdoch University, Murdoch, WA Australia 6150.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]